Welcome to Cambridge Epigenetix

 

Improving Health Through Measurement Of The Epigenome

At Cambridge Epigenetix (CEGX) we believe that methylation matters to human health. So we are developing best in class tools to make studying DNA methylation as easy as studying DNA sequence.

CEGX brings together world leading experts in epigenetics, genomics and the development of next generation sequencing technology. The company is headquartered in Cambridge, UK, and is financed by leading venture capital companies including GV (Google Ventures), Sequoia Capital and Syncona.


About Us
 

Our Products

TrueMethyl
Seq

Sufficient for 24 oxidative bisulfite (oxBS) reactions and 24 bisulfite (BS)-only reactions

Full Details

TrueMethyl
Array

Sufficient for 96 oxidative bisulfite (oxBS) reactions and 96 bisulfite (BS)-only reactions

Full Details

TrueMethyl
Whole-Genome

For the preparation of 48 TrueMethyl® converted and indexed DNA libraries for Illumina® sequencing

Full Details

Partners

Cambridge Epigenetix have partnered with the world's foremost biotechnology companies and research labs to enable world class epigenetic research.

David H. Murdock Research Institute
Illumina
University of Exeter
Babraham Institute
CRG
Institut Curie
CNAG
University of Oklahoma Health Sciences Center
CNG
CEA